关于CAR-T细胞在固体瘤中的有限功能以及潜在解决方案的机制性见解
Taku Kouro1, Tetsuro Sasada1, Kohzoh Imai2
1Division of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan.; Cancer Vaccine and Immunotherapy Center, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa 241-8515, Japan..
International immunopharmacology
|June 6, 2025
概括
化学抗原受体T (CAR-T) 细胞疗法对血液癌症有希望,但在固体瘤中面临挑战. 本综述探讨了抗原选择和瘤微环境等障碍,以及潜在的解决方案.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体T (CAR-T) 细胞疗法对血液恶性瘤有效.
- 显著的挑战阻碍了在固体瘤中CAR-T细胞疗法的有效性.
研究的目的:
- 为实体瘤中CAR-T细胞治疗的障碍提供全面的概述.
- 讨论改善固体瘤中CAR-T细胞治疗的潜在对策.
主要方法:
- 关于对固体瘤进行CAR-T细胞治疗的当前研究的文献综述.
- 分析已识别的障碍物,包括向抗原选择,物理透和免疫抑制.
- 探索克服这些障碍的拟议策略.
主要成果:
- 确定了关键障碍:选择适当的瘤抗原的困难,CAR-T细胞透的物理障碍,以及瘤微环境的免疫抑制性.
- 目前正在研究各种对策,以增强固体瘤中CAR-T细胞的功能.
结论:
- 克服已识别的障碍对于扩大CAR-T细胞疗法的应用到固体瘤至关重要.
- 需要对新策略进行进一步的研究,以改善固体瘤治疗中的CAR-T细胞治疗结果.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


